J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Classement en actions
#3893
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Prix de l'action
$26.58
Dernière synchronisation: 2026-07-23
Capitalisation boursière
$4.24B
Changement (1 jour)
0.00%
Changement (1 an)
38.40%
Pays
IN
Échange J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Catégorie
Healthcare
Ratio P/B pour J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Ratio P/B au October 2026 TTM : 9.27
Selon les derniers rapports financiers et le cours de l'action de J. B. Chemicals & Pharmaceuticals Limited, le ratio cours/valeur comptable actuel (TTM) est 9.27. À la fin de 2024, le ratio P/B était de 8.99.
Historique du ratio P/B pour J. B. Chemicals & Pharmaceuticals Limited de 2005 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 9.27 | 29.34% |
| 2025 | 7.17 | -20.26% |
| 2024 | 8.99 | 45.87% |
| 2023 | 6.16 | 7.98% |
| 2022 | 5.71 | 6.43% |
| 2021 | 5.36 | 91.96% |
| 2020 | 2.79 | 36.00% |
| 2019 | 2.05 | 12.86% |
| 2018 | 1.82 | -15.48% |
| 2017 | 2.15 | 11.29% |
| 2016 | 1.93 | 13.81% |
| 2015 | 1.70 | 63.33% |
| 2014 | 1.04 | 64.51% |
| 2013 | 0.63 | 18.87% |
| 2012 | 0.53 | -67.05% |
| 2011 | 1.62 | 53.39% |
| 2010 | 1.05 | 60.86% |
| 2009 | 0.65 | -29.39% |
| 2008 | 0.93 | -41.37% |
| 2007 | 1.58 | -43.38% |
| 2006 | 2.79 | 19.52% |
| 2005 | 2.34 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -45.64% |
IN
|
